Our findings suggest that neutralizing TGF-β1 or activating the cGAS-STING pathway could restore the expression of the antigen presentation system and immunosuppressive signal in MM cells affected by Tregs, potentially providing therapeutic strategies for MM treatment. This evidence concerns the gene CGAS and Miyoshi myopathy.